Emerging market focus delivers Benecol cholesterol reduction bounty

By Shane STARLING contact

- Last updated on GMT

Emerging market focus delivers Benecol cholesterol reduction bounty

Related tags: Marketing

Finnish ag-ingredients-branded foods player Raisio has turned in its best ever quarter and said a focus on emerging markets is driving ongoing sales growth in the sluggish plant stanol, cholesterol reduction category.

In its 2013 first half report that saw it win €11m in EBIT profit on €148.6m turnover, Raisio said the Benecol end-product’s best growth was coming from Chile, Ecuador and Indonesia. Half year revenues were €276.9m with EBIT of €19m across the firm's portfolio of raw materials, ingredients and food products.

While not releasing specific numbers for EU health claim-backed Benecol, Raisio said EU sales increased compared to H1 2012, although issues remained in Poland.

“Intensified competition in one of the largest Benecol countries, Poland, reduced the sales development in Benecol margarines. Raisio took over the sale of Benecol margarines in February-March. We believe that the situation will level off as a result of our own marketing activities.”

An Asian and latin American focus announced several years ago was starting to pay off. “In sales of Benecol products, the share of emerging markets of Asia and South America is still low, but our partners' activity and investments are shown in good sales growth.”

“Raisio will actively continue its efforts to launch Benecol products into new markets, especially in Asia.”

According to Euromonitor, Raisio's strongest EU markets in terms of the sterol-stanol product market share are Poland (63.9% yoghurt; 66% oils and fats), the UK (76.6% yoghurt; 28.4% oils and fats) and Finland (30.2% yoghurt; 21.1% oils and fats ).

pro.activrange

Pro.activ

Euromonitor puts the global market for these kinds of products at about €2.45bn with Unilever’s pro.activ brand and Raisio’s Benecol brands the runaway leaders. Raisio engages in brand licensing to others like McNeil Nutritionals while pro.activ appears under Unilever brands like Flora and Becel in different countries.

For the Pro.activ brand alone, Euromonitor noted that between 2007 and 2012, spreads had increased in sales from €309m to €394m. Its yoghurt-based products fared less well, sliding from €124m to €104m. Overall the range was worth about €500 in 2012.

“We expect the brand to continue to grow in oils and fats in 2013 by approximately €15m but sales in yoghurts will continue to see a negative growth of about €2.2m,” ​the market analyst observed.

Related news

Show more

Related products

show more

MenaQ7® Partners Benefit From K2 Outreach

MenaQ7® Partners Benefit From K2 Outreach

NattoPharma USA, Inc. | 22-Apr-2019 | Case Study

MenaQ7® K2 as MK-7 provides health benefits for all ages. That is a fact clinically proven by NattoPharma and communicated to practitioners and consumers...

Outsmart brain-ageing in healthy older adults

Outsmart brain-ageing in healthy older adults

DIANA, FOOD DIVISION | 02-Apr-2019 | Technical / White Paper

What happens when you combine the brain health benefits of blueberries with those of grapes?
Both Canadian wild blueberries and French grapes are...

K2 for Heart Health? MenaQ7 Only Proven, Patented

K2 for Heart Health? MenaQ7 Only Proven, Patented

NattoPharma USA, Inc. | 22-Oct-2018 | Research Study

Vitamin K2 has earned media and the medical community’s attention due to a strong body of evidence showing it simultaneously supports bone and cardiovascular...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars